Literature DB >> 30428

Benzodiazepines in depressive disorders.

A F Schatzberg, J O Cole.   

Abstract

Some investigators have found benzodiazepines effective in the treatment of anxious depression and thus have argued that benzodiazepines were "antidepressants." We reviewed the literature on benzodiazepines in depressive disorders. Comparative studies indicate they are less effective than standard antidepressants in the treatment of several types of depressive illnesses. Although they display definite anxiolytic properties and may elevate mood, they exert limited effect on the core symptoms of endogenous depression. An argument is made that benzodiazepines are primarily anxiolytic rather than antidepressant.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 30428     DOI: 10.1001/archpsyc.1978.01770350085008

Source DB:  PubMed          Journal:  Arch Gen Psychiatry        ISSN: 0003-990X


  23 in total

Review 1.  Benzodiazepines. Depressants or antidepressants?

Authors:  J W Tiller; I Schweitzer
Journal:  Drugs       Date:  1992-08       Impact factor: 9.546

2.  Network analysis of depression and anxiety symptom relationships in a psychiatric sample.

Authors:  C Beard; A J Millner; M J C Forgeard; E I Fried; K J Hsu; M T Treadway; C V Leonard; S J Kertz; T Björgvinsson
Journal:  Psychol Med       Date:  2016-09-14       Impact factor: 7.723

3.  Adinazolam, a new triazolobenzodiazepine, and imipramine in the treatment of major depressive disorder.

Authors:  J D Amsterdam; M Kaplan; L Potter; L Bloom; K Rickels
Journal:  Psychopharmacology (Berl)       Date:  1986       Impact factor: 4.530

4.  Benzodiazepines in the treatment of depressive, borderline personality, and schizophrenic disorders.

Authors:  A F Schatzberg; J O Cole
Journal:  Br J Clin Pharmacol       Date:  1981       Impact factor: 4.335

5.  Benzodiazepines: clinical pharmacology and therapeutic use.

Authors:  C Bellantuono; V Reggi; G Tognoni; S Garattini
Journal:  Drugs       Date:  1980-03       Impact factor: 9.546

Review 6.  Comorbidity of anxiety and depression in children and adolescents: 20 years after.

Authors:  Colleen M Cummings; Nicole E Caporino; Philip C Kendall
Journal:  Psychol Bull       Date:  2013-11-11       Impact factor: 17.737

Review 7.  Integrating clinical and research psychiatry.

Authors:  J M de Groot; S H Kennedy
Journal:  J Psychiatry Neurosci       Date:  1995-03       Impact factor: 6.186

8.  Amitriptyline and oxaprotiline in the treatment of hospitalized depressive patients. Clinical aspects, psychophysiology, and drug plasma levels.

Authors:  H Giedke; H Gaertner; U Breyer-Pfaff; W Rein; D Axmann
Journal:  Eur Arch Psychiatry Neurol Sci       Date:  1986

Review 9.  Alprazolam: a review of its pharmacodynamic properties and efficacy in the treatment of anxiety and depression.

Authors:  G W Dawson; S G Jue; R N Brogden
Journal:  Drugs       Date:  1984-02       Impact factor: 9.546

Review 10.  Treatment considerations for the depressed geriatric medical patient.

Authors:  H G Koenig
Journal:  Drugs Aging       Date:  1991 Jul-Aug       Impact factor: 3.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.